Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022602
Filing Date
2022-11-07
Accepted
2022-11-07 16:12:03
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20220930.htm   iXBRL 10-Q 4576127
2 EX-31.1 me-ex31_1.htm EX-31.1 32549
3 EX-31.2 me-ex31_2.htm EX-31.2 30151
4 EX-32.1 me-ex32_1.htm EX-32.1 20619
5 EX-32.2 me-ex32_2.htm EX-32.2 20603
  Complete submission text file 0000950170-22-022602.txt   18659636

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20220930_cal.xml EX-101.CAL 54086
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220930_pre.xml EX-101.PRE 585019
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220930_lab.xml EX-101.LAB 720057
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20220930_def.xml EX-101.DEF 413730
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220930.xsd EX-101.SCH 93341
74 EXTRACTED XBRL INSTANCE DOCUMENT me-20220930_htm.xml XML 4945683
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 221365548
SIC: 2834 Pharmaceutical Preparations